The medical appointment specialist announces a funding operation of 500 million euros, valuing the company at 5.8 billion euros.
By
In France, 2021 had been the year of all records for fundraising for French start-ups: 11.5 billion euros of private money injected into the ecosystem, a historic operation of 586 million euros, carried out by the Non-Fundible Takens Specialist (NFT, “non-fungible chips”) Sorare, in September, an unpublished number (12) of new unicorns created, these start-ups valued at more than 1 billion dollars (910 million euros) …
A brand guest was missing at the party: Doctolib, the most prominent start-up, during the sanitary crisis, with the deployment of the teleconsultation, participation in testing and vaccination campaigns. Why did not this company benefit from attracting new investors at a time when it had never seemed as easy to attract fresh agent? The anomaly is now rectified. By announcing a financing operation of 500 million euros, Tuesday, March 15, it now became the most valued French start-up, at 5.8 billion euros, dethroning Back Market (5.1 billion euros) , which was mounted on the first step of the podium, with its fundraising of 450 million euros, January 11, 2022.
In fact, the European leader in medical appointments did not remain completely inactive, since the 150 million euros lifted in March 2019. In the meantime, he made an operation on which he did not communicate. Since its inception, the company has, in any case, managed to attract 900 million euros of funding, and it would have certainly been able to get more. “We had solicitations of full other investors”, in recent months, says Stanislas Niox-Chateau, the CEO and co-founder of the company.
European sovereignty
For his last round table, he preferred to turn to two of his historic investors, Eurazeo and Bpifrance, which is rather seen with a good eye for a company that plays full map of European sovereignty. The envelope of 500 million euros includes a minority share of debt.
For Mr. Niox-Chateau, the new valuation of Doctolib reflects, “above all, the trustworthy confidence in [the] team, and [their] ability to create value for patients and Health professionals “. Especially admits that this amount of 5.8 billion euros is “pretty decorreled of the economic size of Doctolib, which remains quite modest, today, since [there] has 150,000 professionals of health that pays between 100 and 200 euros per month “. It can be deduced that the turnover of the company is located in a wide range, between 180 million and 360 million euros.
You have 48.5% of this article to read. The rest is reserved for subscribers.